NEI offers grant for clinical trials on vision disorders, gene-transfer, and stem cell therapy; Resources provided for imaging and lab services in multi-center or high-risk trials.
Funder: National Institutes of Health
Due Dates: May 25, 2025 (New/Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | September 25, 2025 (New/Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | January 25, 2026 (New/Renewal/Resubmission/Revision) | May 7, 2026 (AIDS)
Funding Amounts: No budget cap; budgets must reflect actual project needs. Maximum project period: 5 years.
Summary: Supports resource centers providing imaging, laboratory, or other services for complex, multi-center clinical trials on vision disorders.
Key Information: Clinical trial required; limited submission; contact NEI scientific staff at least 12 weeks before applying.
This opportunity, offered by the National Eye Institute (NEI) at NIH, funds Resource Centers that provide essential services—such as imaging, laboratory, or other specialized support—for large, multi-center, or high-risk clinical trials focused on vision disorders. The program is designed to support investigator-initiated clinical trials that evaluate interventions for screening, diagnosing, preventing, or treating vision disorders, or that compare the effectiveness of established interventions. Resource Centers are expected to play a critical role in the organization, quality assurance, and data management of these complex studies.
The NEI UG1 mechanism typically funds a group of companion grants, including Chair’s Grants, Coordinating Centers, and Resource Centers, to ensure robust oversight and performance monitoring for high-impact clinical research.